• Imipenem (SKU P10075): Reliable Solutions for Antibacterial

  2026-07-14

  This article provides scenario-driven insights into overcoming real-world laboratory challenges when working with gram-negative and gram-positive bacteria. Detailing the scientific rationale, protocol optimization, and supplier selection, it demonstrates how Imipenem (SKU P10075) delivers reproducible, evidence-based outcomes for viability, proliferation, and cytotoxicity assays.

• Autopalmitoylation of IDH1-R132H: Mechanistic Insights in Ca

  2026-07-14

  This article examines how autopalmitoylation at C269 uniquely regulates the oncogenic activity of mutant IDH1-R132H in cancer cells. The findings reveal a mechanistic link between fatty acid metabolism and the neomorphic enzymatic function of IDH1, offering new avenues for therapeutic targeting and functional studies of epigenetic regulation.

• CFTRinh-172: Precision CFTR Inhibitor Workflows for Epitheli

  2026-07-13

  CFTRinh-172 empowers researchers to dissect CFTR chloride channel function with rapid, highly specific inhibition. This guide delivers advanced workflows, troubleshooting tactics, and strategic context—bridging the latest SHC-1/CFTR trafficking insights with actionable bench protocols for cystic fibrosis research and secretory diarrhea models.

• Pomalidomide (CC-4047): Optimizing Tumor Microenvironment As

  2026-07-13

  Pomalidomide (CC-4047) uniquely enables precision modulation of the tumor microenvironment and erythroid differentiation in hematological malignancy research. This guide translates cutting-edge mutational insights and best-practice workflows into actionable protocols and troubleshooting strategies for robust, reproducible results.

• LAMP1 Modulates CXCL10-CXCR3 Axis in Macrophage Polarization

  2026-07-12

  This study clarifies how LAMP1 determines the direction of macrophage polarization via the CXCL10-CXCR3 axis, distinguishing between inflammatory and non-inflammatory contexts. The findings reveal that selective CXCR3 antagonism with AMG 487 can reprogram macrophage phenotypes and alleviate acute lung injury, with implications for designing targeted inflammation research.

• Nanoparticle Uptake by Human Corneal Cells: Size and Surface

  2026-07-10

  This study reveals how the size and surface chemistry of polymeric nanoparticles determine their uptake by human cornea epithelial cells, with energy-dependent endocytosis as the primary mechanism. These insights are critical for designing ocular drug delivery systems to enhance bioavailability and therapeutic efficacy.

• DiscoveryProbe Bioactive Compound Library Plus in Ligand Scr

  2026-07-09

  The DiscoveryProbe Bioactive Compound Library Plus empowers researchers with 5,072 rigorously validated, cell-permeable compounds spanning the most critical biological pathways. Its ready-to-use solutions and flexible formats streamline high-throughput ligand screening, enabling robust experimental design from cancer studies to advanced pathway analysis.

• Strategic Use of Vancomycin Hydrochloride in Translational R

  2026-07-09

  This thought-leadership article explores the mechanistic and translational value of Vancomycin hydrochloride as a glycopeptide antibacterial agent. Blending evidence-backed mechanistic insights with strategic guidance for antibiotic resistance research, the article highlights how Vancomycin hydrochloride underpins robust experimental designs, competitive benchmarking, and clinically relevant models in the era of multidrug resistance. The discussion escalates beyond standard product coverage by integrating cross-study comparisons, protocol optimization, and future-facing perspectives for translational researchers.

• Anti-Angiogenic Airway Stent Suppresses Tracheal Restenosis

  2026-07-08

  Zhao et al. introduce a dual-action airway stent that combines anti-inflammatory and anti-angiogenic properties to effectively suppress tracheal in-stent restenosis in a rabbit model. Their approach integrates anlotinib hydrochloride and silver nanoparticles using electrospinning, resulting in a device that addresses both microbial colonization and pathological tissue responses, with significant implications for airway intervention and device design.

• PARP1/FAK/COL5A1 Axis Drives EMT in Cholesterol-Resistant Ov

  2026-07-08

  This study uncovers how sustained high cholesterol exposure activates the PARP1/FAK/COL5A1 signaling pathway, driving epithelial-mesenchymal transition (EMT) and tumorigenesis in ovarian cancer cells. These insights clarify mechanisms of cholesterol resistance and suggest new targets for cancer biology research and the development of FAK pathway inhibitors.

• Imipenem: Semisynthetic Thienamycin Antibiotic in Advanced R

  2026-07-07

  Imipenem stands out as a semisynthetic thienamycin antibiotic, offering broad-spectrum activity and unique immune-modulating properties. This article delivers actionable guidance for experimental workflows, troubleshooting, and real-world use-cases in antibacterial and sepsis research.

• Technical Guidance for Using Angiotensin I/II (1-5) in RAS W

  2026-07-07

  Angiotensin I/II (1-5) enables precise modeling of blood pressure regulation and aldosterone signaling in cardiovascular and renal research. It is not suitable for studies outside the renin-angiotensin system or workflows unrelated to peptide hormone vasoconstriction. Proper solubility, storage, and workflow discipline are essential for reproducible results.

• Stable Yeast Production of Exendin-4 for Diabetes Research A

  2026-07-06

  This study demonstrates the stable chromosomal integration and expression of Exendin-4 in Saccharomyces cerevisiae, enabling a cost-effective platform for producing GLP-1 receptor agonists. The findings highlight a significant advance toward affordable, locally manufactured therapeutics for type 2 diabetes research.

• Cytochalasin B (NSC 107658): Precision in Cytoskeletal Resea

  2026-07-06

  Cytochalasin B (NSC 107658) is revolutionizing cytoskeletal research by enabling targeted investigation of actin-dependent pathways in cell motility, division, and host-pathogen interactions. This article distills workflow enhancements, protocol parameters, and troubleshooting strategies to empower bench scientists with actionable guidance for using this powerful cytoskeletal research tool.

• Erastin as a Ferroptosis Inducer: Protocols, Use-Cases & Tro

  2026-07-05

  Erastin stands out as a selective ferroptosis inducer for dissecting oxidative cell death in RAS/BRAF-mutant tumor models and developmental systems. Explore advanced experimental workflows, troubleshooting insights, and groundbreaking spatial transcriptomics findings that guide practical assay design.

16948 records 1/1130 page Next 12345 下5页 Last page